The UK’s Crown Commercial Service (CCS) has announced the launch of G-Cloud 15 (GC15), the next iteration of the government’s flagship cloud-services framework.
New data from the REACT study finds that 14% of the UK population have antibodies against COVID-19 now, but that vaccine hesitancy is currently highest in London.
Michael Foote, Director of Quote Goat, discusses what financial support is available for businesses that aren't eligible for the government's new lockdown grants, including the Self Employed Income Support Scheme.
Karina Malhotra, founder and MD, Acumentice, explores how technology is being used to solve the elective care conundrum and to what extent emerging tech can make a credible difference on the front line.
Neil Gordon, Chief Executive of Subsea UK, charts the move towards energy transition, green energy and the ultimate goal of net-zero, including comment on the burgeoning Asia-Pacific market.
New documents from the FDA show that the Johnson & Johnson vaccine appears to be 86% effective against COVID-19 - signalling that it will soon be approved in the US.
Steve Rafferty, UK and Ireland Manager, RingCentral, explains how leaders in government organisations can help to ease data storage anxiety through education.
Michael Slimak Ph.D., retired National Program Director for the Sustainable & Healthy Communities Research Program at the U.S. Environmental Protection Agency (EPA), explores the most pressing challenges today that reflect the need to understand interdependencies between the natural and social sciences.
According to a new study, COVID-19 infection in pregnancy is not associated with stillbirth or early neonatal death but it may increase the risk of pre-term birth.
Grainne Elliott, CMO of Thrive, describes four things that employees of local authorities need to support their wellbeing both on and off the job and can be delivered via this new emphasis on digital tools.
Michael Morrison, Senior Researcher in Social Science at the University of Oxford, illustrates the importance of emerging biomedical innovations in the UK.
Michael Morrison, Senior Researcher in Social Science at the Centre for Health, Law and Emerging Technologies (HeLEX), University of Oxford, sheds light on the promises as well as biomodifying technologies for the UK.
